G Lapeyre

859 total citations · 1 hit paper
16 papers, 582 citations indexed

About

G Lapeyre is a scholar working on Surgery, Cardiology and Cardiovascular Medicine and Epidemiology. According to data from OpenAlex, G Lapeyre has authored 16 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 3 papers in Cardiology and Cardiovascular Medicine and 3 papers in Epidemiology. Recurrent topics in G Lapeyre's work include Immune Cell Function and Interaction (3 papers), Cardiac Arrest and Resuscitation (2 papers) and Autoimmune and Inflammatory Disorders Research (2 papers). G Lapeyre is often cited by papers focused on Immune Cell Function and Interaction (3 papers), Cardiac Arrest and Resuscitation (2 papers) and Autoimmune and Inflammatory Disorders Research (2 papers). G Lapeyre collaborates with scholars based in Switzerland, United States and France. G Lapeyre's co-authors include Cristina de Min, Philippe Jacqmin, Fabrizio De Benedetti, Franca Fagioli, Franco Locatelli, Timothy Garrington, Michael B. Jordan, Simone Cesaro, Anupama Rao and Barbara Degar and has published in prestigious journals such as New England Journal of Medicine, Anesthesiology and Annals of the Rheumatic Diseases.

In The Last Decade

G Lapeyre

16 papers receiving 562 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis

2020 311 citations Franco Locatelli, Michael B. Jordan et al. New England Journal of Medicine profile →

Peers

G Lapeyre

IMMUN

HEMAT

ID

SURGE

MB

Maria Ballabio Italy

Olha Halyabar United States

Balahan Makay Türkiye

Ashley Teusink‐Cross United States

Julien Carvelli France

M F Kahn France

Lauren K. Meyer United States

Alexander Eser Austria

Bon San Koo South Korea

Jingan Lou China

Maria Ballabio Italy

G Lapeyre

360 ×1.2

IMMUN

419 ×1.7

HEMAT

202 ×1.5

ID

217 ×2.3

SURGE

83 ×1.1

MB

Citations per year, relative to G Lapeyre G Lapeyre (= 1×) peers Maria Ballabio

Countries citing papers authored by G Lapeyre

Since Specialization

Citations

This map shows the geographic impact of G Lapeyre's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G Lapeyre with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G Lapeyre more than expected).

Fields of papers citing papers by G Lapeyre

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G Lapeyre. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G Lapeyre. The network helps show where G Lapeyre may publish in the future.

Co-authorship network of co-authors of G Lapeyre

This figure shows the co-authorship network connecting the top 25 collaborators of G Lapeyre. A scholar is included among the top collaborators of G Lapeyre based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G Lapeyre. G Lapeyre is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

1.

Dhaenens, Claire‐Marie, Isabelle Audo, A. Lecleire–Collet, et al.. (2024). The phenotypic spectrum of CEP250 gene variants. Ophthalmic Genetics. 46(4). 354–361. 1 indexed citations

2.

Lapeyre, G, et al.. (2021). Syndrome de Cogan. Journal Français d Ophtalmologie. 44(7). e419–e421. 1 indexed citations

3.

Locatelli, Franco, Michael B. Jordan, Carl E. Allen, et al.. (2020). Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis. New England Journal of Medicine. 382(19). 1811–1822. 311 indexed citations breakdown →

4.

Choy, Ernest, Iain B. McInnes, Kathy de Graaf, et al.. (2019). Efficacy and safety of NI-0101, an anti-toll-like receptor 4 monoclonal antibody, in patients with rheumatoid arthritis after inadequate response to methotrexate: a phase II study. Annals of the Rheumatic Diseases. 79(3). 316–323. 58 indexed citations

5.

Lapeyre, G, François Guilhot, Walter Ferlin, et al.. (2018). NI‐0801, an anti‐chemokine (C‐X‐C motif) ligand 10 antibody, in patients with primary biliary cholangitis and an incomplete response to ursodeoxycholic acid. Hepatology Communications. 2(5). 492–503. 38 indexed citations

6.

Lapeyre, G, Eveline P. van Poelgeest, Philippe Jacqmin, et al.. (2016). Evidence of NI‐0101 pharmacological activity, an anti‐TLR4 antibody, in a randomized phase I dose escalation study in healthy volunteers receiving LPS. Clinical Pharmacology & Therapeutics. 101(2). 200–208. 68 indexed citations

7.

Shang, Limin, G Lapeyre, Eric Hatterer, et al.. (2015). AB0451 NI-0101, a Monoclonal Antibody Targeting Toll Like Receptor 4 (TLR4) Being Developed for Rheumatoid Arthritis (RA) Treatment with a Potential for Personalized Medicine. Annals of the Rheumatic Diseases. 74. 1046–1046. 17 indexed citations

8.

Bracaglia, Claudia, Antonio Gatto, Manuela Pardeo, et al.. (2015). Anti interferon-gamma (IFNγ) monoclonal antibody treatment in a patient carrying an NLRC4 mutation and severe hemophagocytic lymphohistiocytosis. Pediatric Rheumatology. 13(S1). 12 indexed citations

9.

Sapin, Emmanuel, et al.. (1996). Coexisting left congenital diaphragmatic hernia and esophageal atresia with tracheoesophageal fistula: Successful management in a premature neonate. Journal of Pediatric Surgery. 31(7). 989–991. 7 indexed citations

10.

Reeth, Olivier Van, et al.. (1994). S-20098, a melatonin agonist, has hypothermic effects after single morning oral administration in humans. Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles). 1 indexed citations

11.

Dubois, Michel Y., et al.. (1992). Pharmacodynamic effects of three doses of ORG 9426 used for endotracheal intubation in humans. Journal of Clinical Anesthesia. 4(6). 472–475. 11 indexed citations

12.

Lapeyre, G, et al.. (1991). [Cardiovascular tolerance to tianeptine].. La Presse Médicale. 20(37). 1858–63. 6 indexed citations

13.

Lapeyre, G, et al.. (1990). A906 EFFECTS OF 3 INTUBATING DOSES OF ORG 9426 IN HUMANS. Anesthesiology. 73(3A). NA–NA. 9 indexed citations

14.

Lechat, P, et al.. (1989). [Contribution of perindopril to the treatment of chronic congestive cardiac insufficiency. Multicenter pilot double blind study versus placebo].. PubMed. 82 Spec No 1. 73–8. 2 indexed citations

15.

Bounhoure, Jean–Paul, et al.. (1989). Value of perindopril in the treatment of chronic congestive heart failure. Multicenter double-blind placebo-controlled study.. PubMed. 11 Suppl 2. 575–86. 22 indexed citations

16.

Murat, I., G Lapeyre, & Claude Saint-Maurice. (1989). Isoflurane Attenuates Baroreflex Control of Heart Rate in Human Neonates. Anesthesiology. 70(3). 395–400. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact